Furthermore, we found that primary ER low-expression and histological grade 3 tumor were associated with worse OS and PR-OS in recurrent patients, which was in consistent with previous studies and may guide our further patient risk classification and treatment decision (29, 31, 32). This evidence concerns the gene PGR and neoplasm.